Clinical trial

Psilocybin for Treatment-Resistant Depression

NCT06230757

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-07-08

PhasePHASE2

Study timeline

Study start (actual)2024-07-08Date precision: day

Registry last updated2026-05-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Anhedoniaunresolved

Treatment Resistant Depressionunresolved

Interventions

Psilocybin 25mgDRUG

Placebo (active placebo)DRUG

Sponsors & collaborators

University of Colorado, Denverlead sponsor

Mapped research locations

AuroraColorado, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06230757 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.